MEI Pharma Net Worth

MEI Pharma Net Worth Analysis

Know MEI Pharma's Top Institutional Investors

Note, although MEI Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow MEI Pharma's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.52 M.

Project MEI Pharma's profitablity

The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.4 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.4.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate MEI Pharma's management efficiency

MEI Pharma has return on total asset (ROA) of 0.2004 % which means that it generated a profit of $0.2004 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.6168 %, meaning that it created $0.6168 on every $100 dollars invested by stockholders. MEI Pharma's management efficiency ratios could be used to measure how well MEI Pharma manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/26/2024, Return On Tangible Assets is likely to grow to 0.45. Also, Return On Capital Employed is likely to grow to 0.46. At this time, MEI Pharma's Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 11/26/2024, Non Current Liabilities Other is likely to grow to about 26.8 M, while Total Current Liabilities is likely to drop slightly above 8.3 M.

MEI Pharma Corporate Filings

MEI Pharma time-series forecasting models is one of many MEI Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MEI Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

MEI Pharma Earnings per Share Projection vs Actual

MEI Pharma Corporate Management

Additional Tools for MEI Stock Analysis